As we speak, AI is revolutionizing cancer research and treatment. Clinical trials, imaging, data analysis, and clinical decision support are a few areas of high impact. How do we embrace AI without letting AI take over? What are the legal and ethical considerations when allowing AI to play a larger and larger role? We hope you’ll join us as we tackle this thorny issue, and hopefully find the best way to leverage AI when managing cancer patients.

The treatment of lung cancer is rapidly evolving. Minimally invasive surgical techniques are shifting towards robotics and more limited anatomic lung resections while medical therapies have expanded with immunotherapy and targeted therapy. Until recently, new systemic therapies were mostly evaluated in the metastatic setting, but there have been several recent studies in resectable lung cancer that have shown impressive clinical outcomes. At this meeting we hope to provide a detailed analysis of the clinical studies, and provoke a robust discussion regarding the multi-disciplinary care of these patients, in hopes of improving outcomes for NSCLC patients in the Spokane region.

We’re excited to present an exclusive opportunity to learn about trends in precision oncology! We will be taking a soup-to-nuts approach and discuss topics across the spectrum of precision oncology including appropriate testing and data infrastructure to leverage genomic results, and ultimately putting it all together to provide meaningful clinical decision support.